Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,464 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 130.72 | 06:32:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 130.72 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 82 | 1,464 | - | 99.14 - 133.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 06:35:46 | 1 | $ 130.60 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 331.07B | 2.53B | - | 60.12B | 365M | 0.14 | 907.15 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 125.71 | 132.80 | 124.89 | 127.74 | 8,865,624 | 5.01 | 3.99% |
| 1 Month | 131.68 | 132.80 | 124.50 | 127.40 | 6,829,302 | -0.96 | -0.73% |
| 3 Months | 126.88 | 133.10 | 119.41 | 125.72 | 8,302,256 | 3.84 | 3.03% |
| 6 Months | 103.21 | 133.10 | 99.80 | 116.61 | 8,394,450 | 27.51 | 26.65% |
| 1 Year | 115.33 | 133.10 | 99.14 | 113.16 | 7,729,144 | 15.39 | 13.34% |
| 3 Years | 78.00 | 133.10 | 70.89 | 93.42 | 9,978,009 | 52.72 | 67.59% |
| 5 Years | 76.64 | 133.10 | 65.25 | 88.33 | 9,974,436 | 54.08 | 70.56% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |
